Search Results - "ENGERS, Darren W"
-
1
Synthesis and structure–activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of Dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe
Published in Bioorganic & medicinal chemistry letters (01-06-2013)“…A structure–activity relationship of the 3- and 6-positions of the pyrazolo[1,5-a]pyrimidine scaffold of the known BMP inhibitors dorsomorphin, 1, LDN-193189,…”
Get full text
Journal Article -
2
Discovery, Structure–Activity Relationship, and Biological Characterization of a Novel Series of 6‑((1H‑Pyrazolo[4,3‑b]pyridin-3-yl)amino)-benzo[d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu4)
Published in Journal of medicinal chemistry (10-01-2019)“…This work describes the discovery and characterization of novel 6-(1H-pyrazolo[4,3-b]pyridin-3-yl)amino-benzo[d]isothiazole-3-carboxamides as mGlu4 PAMs…”
Get full text
Journal Article -
3
Discovery and characterization of a potent and selective inhibitor of Aedes aegypti inward rectifier potassium channels
Published in PloS one (06-11-2014)“…Vector-borne diseases such as dengue fever and malaria, which are transmitted by infected female mosquitoes, affect nearly half of the world's population. The…”
Get full text
Journal Article -
4
Challenges in the development of an M 4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs
Published in Bioorganic & medicinal chemistry letters (15-01-2017)“…This letter describes the chemical optimization of a novel series of M positive allosteric modulators (PAMs) based on a 5-amino-thieno[2,3-c]pyridazine core,…”
Get full text
Journal Article -
5
Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders
Published in Drug discovery today. Technologies (2013)“…Allosteric modulation has emerged as an innovative pharmacological approach to selectively activate or inhibit several Class C GPCRs. Of the Class C GPCRs,…”
Get full text
Journal Article -
6
Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Published in ACS medicinal chemistry letters (09-02-2017)“…Herein, we report the structure–activity relationships within a series of potent, selective, and orally bioavailable muscarinic acetylcholine receptor 4 (M4)…”
Get full text
Journal Article -
7
Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype
Published in ACS bio & med chem au (15-12-2021)“…In the course of optimizing an M1 PAM chemotype, introduction of an ether moiety unexpectedly abolished M1 PAM activity while engendering a “molecular switch”…”
Get full text
Journal Article -
8
Synthesis, SAR and Unanticipated Pharmacological Profiles of Analogues of the mGluR5 Ago‐potentiator ADX‐47273
Published in ChemMedChem (01-04-2009)“…An iterative analogue library synthesis strategy rapidly developed comprehensive SAR for the mGluR5 ago‐potentiator ADX‐47273. This effort identified key…”
Get full text
Journal Article -
9
M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition
Published in Neuropsychopharmacology (New York, N.Y.) (01-07-2018)“…Highly selective positive allosteric modulators (PAMs) of the M1 subtype of muscarinic acetylcholine receptor have emerged as an exciting new approach for…”
Get full text
Journal Article -
10
M 1 -positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition
Published in Neuropsychopharmacology (New York, N.Y.) (01-07-2018)“…Highly selective positive allosteric modulators (PAMs) of the M subtype of muscarinic acetylcholine receptor have emerged as an exciting new approach for…”
Get full text
Journal Article -
11
Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective Kv7.1 (KCNQ1) potassium channel activator
Published in Bioorganic & medicinal chemistry letters (01-09-2012)“…A high-throughput screen utilizing a depolarization-triggered thallium influx through KCNQ1 channels was developed and used to screen the MLSMR collection of…”
Get full text
Journal Article -
12
M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder
Published in Biological psychiatry (1969) (15-06-2019)“…The prefrontal cortex (PFC) integrates information from multiple inputs to exert top-down control allowing for appropriate responses in a given context. In…”
Get full text
Journal Article -
13
M 1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder
Published in Biological psychiatry (1969) (15-06-2019)“…The prefrontal cortex (PFC) integrates information from multiple inputs to exert top-down control allowing for appropriate responses in a given context. In…”
Get full text
Journal Article -
14
An insecticide resistance-breaking mosquitocide targeting inward rectifier potassium channels in vectors of Zika virus and malaria
Published in Scientific reports (16-11-2016)“…Insecticide resistance is a growing threat to mosquito control programs around the world, thus creating the need to discover novel target sites and…”
Get full text
Journal Article -
15
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu 7 Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1 H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)
Published in Journal of medicinal chemistry (14-02-2019)“…Herein, we report the discovery of a new, orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 (mGlu ) negative allosteric modulator (NAM)…”
Get full text
Journal Article -
16
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1
Published in Bioorganic & medicinal chemistry letters (01-09-2021)“…[Display omitted] This Letter describes the synthesis and optimization of a series of heteroaryl-pyrrolidinone positive allosteric modulators (PAMs) of the…”
Get full text
Journal Article -
17
Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063
Published in The Journal of pharmacology and experimental therapeutics (01-09-2019)“…Glucose-stimulated insulin secretion from pancreatic -cells is controlled by ATP-regulated potassium (K ) channels composed of Kir6.2 and sulfonylurea receptor…”
Get more information
Journal Article -
18
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M 1
Published in Bioorganic & medicinal chemistry letters (01-09-2021)“…This Letter describes the synthesis and optimization of a series of heteroaryl-pyrrolidinone positive allosteric modulators (PAMs) of the muscarinic…”
Get full text
Journal Article -
19
Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors
Published in Bioorganic & medicinal chemistry letters (15-09-2020)“…[Display omitted] The activin-like kinases are a family of kinases that play important roles in a variety of disease states. Of this class of kinases, ALK2,…”
Get full text
Journal Article -
20
Surveying heterocycles as amide bioisosteres within a series of mGlu 7 NAMs: Discovery of VU6019278
Published in Bioorganic & medicinal chemistry letters (15-05-2019)“…This letter describes a diversity-oriented library approach to rapidly assess diverse heterocycles as bioisosteric replacements for a metabolically labile…”
Get full text
Journal Article